Abstract
By linking a guide sequence to the catalytic RNA subunit of RNase P (M1 RNA), we constructed a functional ribozyme (M1GS RNA) that targets the overlapping mRNA region of two human cytomegalovirus (HCMV) capsid proteins, the capsid scaffolding protein (CSP) and assemblin, which are essential for viral capsid formation. The ribozyme efficiently cleaved the target mRNA sequence in vitro. Moreover, a reduction of >85% in the expression of CSP and assemblin and a reduction of 4000-fold in viral growth were observed in the HCMV-infected cells that expressed the functional ribozyme. In contrast, there was no significant reduction in viral gene expression and growth in virus-infected cells that either did not express the ribozyme or produced a 'disabled' ribozyme carrying mutations that abolished its catalytic activity. Characterization of the effects of the ribozyme on the HCMV lytic replication cycle further indicates that the expression of the functional ribozyme specifically inhibits the expression of CSP and assemblin, and consequently blocks viral capsid formation and growth. Our results provide the direct evidence that RNase P ribozymes can be used as an effective gene-targeting agent for antiviral applications, including abolis...Continue Reading
References
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y YuanS Altman
Aug 17, 1990·Science·A C Forster, S Altman
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A R WelchW Gibson
Mar 9, 1990·Science·N SarverJ J Rossi
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A M PyleT R Cech
Dec 1, 1990·Genes & Development·M Ares, A H Igel
Dec 1, 1988·The Journal of Infectious Diseases·G J DemmlerR A May
Dec 1, 1983·Cell·C Guerrier-TakadaS Altman
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·C Guerrier-TakadaS Altman
Feb 15, 1995·Genes & Development·F Liu, S Altman
Sep 6, 1994·Biochemistry·D N FrankN R Pace
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M YuF Wong-Staal
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·H ZhuT Shenk
Jun 11, 1998·Science·N LanB A Sullenger
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·D Plehn-Dujowich, S Altman
Oct 6, 1998·Annual Review of Biochemistry·D N Frank, N R Pace
Nov 14, 1998·RNA·D KawaF Liu
Nov 26, 1998·Human Gene Therapy·F Wong-StaalD J Looney
Feb 18, 1999·Chemistry & Biology·J J Rossi
Apr 1, 2000·The Journal of Biological Chemistry·A F KilaniF Liu
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·P TrangF Liu
Sep 1, 2000·Journal of Molecular Biology·P TrangF Liu
Dec 4, 2003·Nature Biotechnology·Lisa J Scherer, John J Rossi
Citations
Jun 3, 2014·Virology Journal·Xinliang MaoGang Li
Mar 10, 2010·New Biotechnology·Eirik Wasmuth Lundblad, Sidney Altman
May 14, 2005·Antiviral Chemistry & Chemotherapy·Michael Markosian, Robyn M Hyde
Jun 27, 2015·Viruses·Zhu YangFenyong Liu